Resource Library

June 13, 2019

The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study is an open-label randomised clinical trial comparing three highly effective, reversible methods of contraception — a progestogen-only injectable called depot-medroxyprogesterone acetate (DMPA), a levonorgestrel implant and the…

As everyone in the field is aware, the NIH conducted an input process last year that concluded with a release of new HIV prevention research priorities that favor long acting, systemic formulations (like vaccines, implants and injectables) and negate the need for short acting, user-controlled,…

The International Partnership for Microbicides (IPM) 2017 annual report takes a look at promising woman-centered technologies that could expand women's prevention options and help empower them to protect their sexual and reproductive health on their own terms. Available in …

Global experts recognize the need to transform conventional models of healthcare to create adolescent responsive health systems. As countries near 80% coverage of voluntary medical male circumcision (VMMC) for those aged 15–49 years, prioritization of younger men becomes critical to VMMC…

In late 2015, the Linkages Across the Continuum of HIV Services for Key Populations (LINKAGES) project established a global acceleration initiative to fast-track and strengthen delivery of a comprehensive package of health services for key populations (KPs) at scale. In this context, “…

This report presents progress made after two years of implementation of the ESA Commitment (2013-2015). Significant progress has already been made thanks to concerted action by governments, civil society, and development partners at national and regional level.

The data presented was…

Under the Preventive Technologies Agreement supported by the US Agency for International Development, FHI 360 implemented two projects designed to increase understanding of the gender issues likely to affect women’s microbicide use. Findings, including the role of male partners, will inform the…

IPM's 2015 annual report looks at promising new technologies in IPM's pipeline that could put the power of HIV prevention in women's hands. These products include IPM's monthly dapivirine ring – the first microbicide to show efficacy in two Phase III trials – and next-generation products that …

The National Department of Health (NDOH) commissioned a Joint Review of the HIV, TB and PMTCT Programmes to be undertaken in 2013. The main purpose of this independent Review, carried out by a multi-disciplinary team of South African and international reviewers, was to assess performance of the…